
- Industry news
Industry news
- Category news
- Reports
- Key trends
- Multimedia
Multimedia
- Journal
- Events
- Suppliers
Suppliers
- Home
- Industry news
Industry news
- Category news
- Reports
- Key trends
- Multimedia
Multimedia
- Events
- Suppliers
Suppliers
Claire Boniface, the marketing and communications manager at Ingood by Olga, spoke with us about the company’s latest Sulfodyne real-life clinical study, which she said underscores its advantages over traditional premenstrual syndrome (PMS) supplements like magnesium and chasteberry. She discussed exciting potential new applications for Sulfodyne in women’s health beyond PMS, including endometriosis and mood disorders, highlighting the company’s mission to address the diverse unmet needs within the women’s health category.
Upcoming webinars

The science of HMOs – A novonesis webinar featuring new clinical findings and ESPGHAN highlights
Novonesis

From boosters to companions: GLP-1 in Food, Beverages and Supplements
Rousselot

Aging Is Inevitable. Longevity Is Negotiable
Sabinsa
















